Search

everythinglearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Human TMEM2 does not break down hyaluronan but helps control its metabolism.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

A specific type II hair keratin was identified and found in hair cortex and tongue cells.

ABCG2 protein marks stem-like skin cells in human epidermis.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Antibodies help identify glycoproteins in normal skin and tumor cells.

Type 2 cytokines IL-4 and IL-13 increase skin's vulnerability to Staphylococcus aureus, which could be important for treating atopic dermatitis.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Different body parts have varying levels of certain hair follicle markers.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

CD200 is not a reliable marker for identifying stem cells in all skin types.

Hair follicles help attract immune cells to minor skin injuries.

Nestin helps identify certain melanoma cells in nodular melanoma.

wAMD patients have higher oxidative stress, suggesting antioxidant treatment may help.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

CD4+ skin cells may be precursors to basal cell carcinoma.

Thymic mesenchymal cells have unique gene expression that supports their specific functions in the thymus.